Free Trial

Star Equity (STRR) Competitors

Star Equity logo
$2.02 -0.01 (-0.49%)
As of 08/1/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STRR vs. FEMY, DRIO, VVOS, IRIX, RVP, ALUR, PETV, NRXS, NXL, and OSRH

Should you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Femasys (FEMY), DarioHealth (DRIO), Vivos Therapeutics (VVOS), IRIDEX (IRIX), Retractable Technologies (RVP), Allurion Technologies (ALUR), PetVivo (PETV), NeurAxis (NRXS), Nexalin Technology (NXL), and OSR (OSRH). These companies are all part of the "medical equipment" industry.

Star Equity vs. Its Competitors

Star Equity (NASDAQ:STRR) and Femasys (NASDAQ:FEMY) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

Star Equity has a net margin of -16.43% compared to Femasys' net margin of -1,242.06%. Star Equity's return on equity of -8.24% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
Star Equity-16.43% -8.24% -3.48%
Femasys -1,242.06%-392.45%-137.15%

Star Equity currently has a consensus price target of $5.00, suggesting a potential upside of 147.52%. Femasys has a consensus price target of $8.67, suggesting a potential upside of 957.43%. Given Femasys' higher probable upside, analysts plainly believe Femasys is more favorable than Star Equity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Star Equity
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.8% of Star Equity shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 33.5% of Star Equity shares are held by company insiders. Comparatively, 11.5% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Star Equity has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Femasys has a beta of -2.56, suggesting that its share price is 356% less volatile than the S&P 500.

Star Equity has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Star Equity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Star Equity$53.36M0.12-$10.44M-$3.43-0.59
Femasys$1.70M15.69-$18.82M-$0.91-0.90

In the previous week, Star Equity's average media sentiment score of 0.00 equaled Femasys'average media sentiment score.

Company Overall Sentiment
Star Equity Neutral
Femasys Neutral

Summary

Star Equity beats Femasys on 8 of the 13 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STRR vs. The Competition

MetricStar EquityDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ Exchange
Market Cap$6.55M$15.83B$14.55B$9.51B
Dividend YieldN/A4.20%3.97%4.09%
P/E Ratio-0.599.227.7923.80
Price / Sales0.124.854.0366.58
Price / Cash6.2333.5032.1457.96
Price / Book0.182.272.005.55
Net Income-$10.44M$951.84M$922.55M$259.03M
7 Day Performance-3.81%-3.41%-3.10%-4.59%
1 Month Performance2.54%0.52%-0.45%4.46%
1 Year Performance-52.02%6.52%4.30%18.03%

Star Equity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STRR
Star Equity
3.1691 of 5 stars
$2.02
-0.5%
$5.00
+147.5%
-55.5%$6.55M$53.36M-0.59460Positive News
FEMY
Femasys
2.7852 of 5 stars
$0.83
-3.6%
$8.67
+939.2%
-27.5%$27.13M$1.63M-0.9230
DRIO
DarioHealth
1.8671 of 5 stars
$0.61
-3.2%
$2.00
+230.6%
-47.1%$26.90M$27.04M-1.08200Upcoming Earnings
VVOS
Vivos Therapeutics
0.7156 of 5 stars
$4.42
-6.5%
$4.82
+8.9%
+138.7%$26.06M$14.63M-2.56160Analyst Upgrade
Short Interest ↑
Gap Down
IRIX
IRIDEX
0.4914 of 5 stars
$1.43
-6.5%
N/A-36.3%$24.01M$48.67M-3.33120Upcoming Earnings
RVP
Retractable Technologies
2.8916 of 5 stars
$0.73
+0.5%
N/A-33.7%$21.77M$33.75M-1.35240News Coverage
Positive News
Gap Down
ALUR
Allurion Technologies
2.1567 of 5 stars
$2.84
-5.3%
$22.83
+703.7%
-87.5%$21.19M$28.30M-0.23501
PETV
PetVivo
N/A$0.79
+2.6%
N/A+30.2%$19.33M$1.05M-1.7620Gap Down
NRXS
NeurAxis
2.6885 of 5 stars
$2.68
-1.3%
$7.00
+161.7%
-22.4%$19.30M$2.93M-1.4519Upcoming Earnings
NXL
Nexalin Technology
2.3657 of 5 stars
$1.08
-4.4%
$5.00
+363.0%
-13.3%$18.55M$170K-1.303News Coverage
Positive News
OSRH
OSR
N/A$0.92
-2.2%
N/AN/A$17.79MN/A0.00N/ANews Coverage

Related Companies and Tools


This page (NASDAQ:STRR) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners